GlassScriptPhysician profile
Susan C Bradshaw
NPI 1588054548
$901.95
in general payments reported to CMS, 2019-2025
18 companies · $349 in 2025
The $349 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $177 · 2023: $21.45 · 2024: $355 · 2025: $349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $724.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $232.94 | 2022-2025 | |
| Pfizer INC. | $104.06 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $99.15 | 2022-2025 | Breztri, Airsupra |
| Glaxosmithkline, LLC. | $73.82 | 2023-2025 | Arexvy, Shingrix |
| Biohaven Pharmaceutical Holding Company LTD. | $59.05 | 2022 | |
| Lilly USA, LLC | $51.11 | 2024-2025 | Mounjaro, Zepbound |
| Amgen INC. | $45.46 | 2022-2025 | Evenity |
| Sumitomo Pharma America, INC. | $30.67 | 2025 | Gemtesa |
| Novartis Pharmaceuticals Corporation | $29.26 | 2024 | |
| Exact Sciences Corporation | $28.80 | 2025 | Cologuard Collection Kit |
| Bausch Health US, LLC | $24.08 | 2024 | Aplenzin |
| Ibsa Pharma INC. | $22.26 | 2024 | Tirosint, Licart |
| Seqirus USA INC | $20.21 | 2025 | Fluad, Flucelvax |
| Hologic Sales and Service, LLC | $19.76 | 2025 | Thinprep 2000 Processor, Aptima |
| Axsome Therapeutics, INC. | $17.49 | 2025 | Symbravo |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $16.17 | 2024 | Slynd |
| Tactile Systems Technology INC | $15.15 | 2024 | Entre Plus, Flexitouch Plus |
| Idorsia Pharmaceuticals US INC | $12.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Bradshaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.